The AHA today submitted comments to the Centers for Medicare & Medicaid Services on an advanced notice of proposed rulemaking on potential options to strengthen the supply chain for American-made personal protective equipment and essential medicines. The AHA agreed with CMS’ approach to provide incentives to hospitals and health systems to purchase domestically made products and said that such incentives should be accessible to as many hospitals as possible, recognize the cost differential for domestically manufactured goods and be implemented without excessive administrative burden. The AHA made additional recommendations to CMS, including making a public designation voluntary based on domestic procurement percentages, implementing separate Medicare payments in a non-budget-neutral manner, and deprioritizing the development of a structural measure in the inpatient quality reporting program. 

Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
The U.S. Trade Representative yesterday announced plans to impose additional tariffs on goods from certain nations that it said had lacked or failed…
Headline
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to…
Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…